MétaCan
Menu
Back to cohort
Record W4385260388 · doi:10.7554/elife.87894

Identifying metabolic features of colorectal cancer liability using Mendelian randomization

2023· article· en· W4385260388 on OpenAlexfundno aff
Caroline J. Bull, Emma Hazelwood, Joshua A. Bell, Vanessa Y. Tan, Andrei‐Emil Constantinescu, Maria Carolina Borges, Danny Legge, Kimberley Burrows, Jeroen R. Huyghe, Hermann Brenner, Sergi Castellvı́-Bel, Andrew T. Chan, Sun‐Seog Kweon, Loı̈c Le Marchand, Li Li, Iona Cheng, Rish K. Pai, Jane C. Figueiredo, Neil Murphy, Marc J. Gunter, Nicholas J. Timpson, Emma E. Vincent

Bibliographic record

VenueeLife · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenetic Associations and Epidemiology
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesNIHR Imperial Biomedical Research CentreInstituto de Salud Carlos IIICancer Council VictoriaOntario Ministry of Research and InnovationNational Health and Medical Research CouncilMedical Research CouncilChonnam National University Hwasun HospitalBiobanco VascoJunta de Castilla y LeónWereld Kanker Onderzoek FondsXunta de GaliciaMutuelle Générale de l'Education NationaleSchool of Public Health, Imperial College LondonElizabeth Blackwell Institute for Health Research, University of BristolDeutsche KrebshilfeAssociazione Italiana per la Ricerca sul CancroVetenskapsrådetStockholms Läns LandstingBundesministerium für Bildung und ForschungMinisterio de Economía y CompetitividadImperial College LondonGeneralitat de CatalunyaNational Cancer InstituteFundación Científica Asociación Española Contra el CáncerKarolinska InstitutetUniversity of CambridgeZonMwInstitut Gustave-RoussyHerzfelder'sche FamilienstiftungGrantová Agentura České RepublikyCanadian Cancer Society Research InstituteMarshfield Clinic Research FoundationInstitut National de la Santé et de la Recherche MédicaleWorld Cancer Research FundKnut och Alice Wallenbergs StiftelseDamon Runyon Cancer Research FoundationUniversity of BristolChonnam National UniversityCentres de Recerca de CatalunyaUmeå UniversitetMinisterstvo Zdravotnictví Ceské RepublikyEuropean CommissionCancerfondenCanadian Institutes of Health ResearchDiabetes UKXarxa de Bancs de Tumors de CatalunyaWorld Health OrganizationMemorial Sloan-Kettering Cancer CenterWellcome TrustCancer Research UKUK Research and InnovationGénome QuébecUniversity of South FloridaSwedish Cancer FoundationNational Heart, Lung, and Blood InstituteFlorida Department of HealthNational Institutes of HealthMike and Josie Harper Cancer Research InstituteWorld Cancer Research Fund InternationalJohns Hopkins UniversityUniverzita Karlova v PrazeMcGill UniversityPelotoniaMoffitt Cancer CenterLigue Contre le CancerDeutsches KrebsforschungszentrumAgència de Gestió d'Ajuts Universitaris i de RecercaNational Institute for Health and Care ResearchDivision of Cancer Prevention, National Cancer InstituteEmory UniversityU.S. Department of Health and Human Services
KeywordsMendelian randomizationColorectal cancerBiologyGeneticsComputational biologyBioinformaticsCancerMedicineGeneGenotypeGenetic variants

Abstract

fetched live from OpenAlex

Background: Recognizing the early signs of cancer risk is vital for informing prevention, early detection, and survival. Methods: To investigate whether changes in circulating metabolites characterize the early stages of colorectal cancer (CRC) development, we examined the associations between a genetic risk score (GRS) associated with CRC liability (72 single-nucleotide polymorphisms) and 231 circulating metabolites measured by nuclear magnetic resonance spectroscopy in the Avon Longitudinal Study of Parents and Children (N = 6221). Linear regression models were applied to examine the associations between genetic liability to CRC and circulating metabolites measured in the same individuals at age 8 y, 16 y, 18 y, and 25 y. Results: The GRS for CRC was associated with up to 28% of the circulating metabolites at FDR-P < 0.05 across all time points, particularly with higher fatty acids and very-low- and low-density lipoprotein subclass lipids. Two-sample reverse Mendelian randomization (MR) analyses investigating CRC liability (52,775 cases, 45,940 controls) and metabolites measured in a random subset of UK Biobank participants (N = 118,466, median age 58 y) revealed broadly consistent effect estimates with the GRS analysis. In conventional (forward) MR analyses, genetically predicted polyunsaturated fatty acid concentrations were most strongly associated with higher CRC risk. Conclusions: These analyses suggest that higher genetic liability to CRC can cause early alterations in systemic metabolism and suggest that fatty acids may play an important role in CRC development. Funding: This work was supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol, the Wellcome Trust, the Medical Research Council, Diabetes UK, the University of Bristol NIHR Biomedical Research Centre, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computational facilities of the Advanced Computing Research Centre, University of Bristol - http://www.bristol.ac.uk/acrc/.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.033
metaresearch head score (Gemma)0.066
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.033
Threshold uncertainty score0.173

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0330.066
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0020.002
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.332
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueeLifeSame topicGenetic Associations and EpidemiologyFrench-language works237,207